Click for best price
Drugs for VancomycinResistant Enterococcus Faecium Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Drugs for Vancomycin-Resistant Enterococcus Faecium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Vancomycin-Resistant Enterococcus Faecium. This report contains market size and forecasts of Drugs for Vancomycin-Resistant Enterococcus Faecium in global, including the following market information:
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Drugs for Vancomycin-Resistant Enterococcus Faecium market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Daptomycin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs for Vancomycin-Resistant Enterococcus Faecium include Alchemia Limited, Alvogen, Aphios Corporation, Cellceutix Corporation, Enanta Pharmaceuticals, Helix BioMedix, LegoChem Biosciences, Lytix Biopharma and MGB Biopharma Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Vancomycin-Resistant Enterococcus Faecium companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment Percentages, by Type, 2022 (%)
Daptomycin
Linezolid
Quinupristin/dalfopristin
Ampicillin
Chloramphenicol
Others
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Vancomycin-Resistant Enterococcus Faecium revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs for Vancomycin-Resistant Enterococcus Faecium revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Vancomycin-Resistant Enterococcus Faecium, market overview.
Chapter 2: Global Drugs for Vancomycin-Resistant Enterococcus Faecium market size in revenue.
Chapter 3: Detailed analysis of Drugs for Vancomycin-Resistant Enterococcus Faecium company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Vancomycin-Resistant Enterococcus Faecium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Drugs for Vancomycin-Resistant Enterococcus Faecium Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Overall Market Size
2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size: 2022 VS 2030
2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Vancomycin-Resistant Enterococcus Faecium Players in Global Market
3.2 Top Global Drugs for Vancomycin-Resistant Enterococcus Faecium Companies Ranked by Revenue
3.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Vancomycin-Resistant Enterococcus Faecium Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Markets, 2022 & 2030
4.1.2 Daptomycin
4.1.3 Linezolid
4.1.4 Quinupristin/dalfopristin
4.1.5 Ampicillin
4.1.6 Chloramphenicol
4.1.7 Others
4.2 By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue & Forecasts
4.2.1 By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2024-2030
4.2.3 By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue & Forecasts
5.2.1 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2024-2030
5.2.3 By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2022 & 2030
6.2 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue & Forecasts
6.2.1 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2024-2030
6.2.3 By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2018-2030
6.3.2 US Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.3.3 Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.3.4 Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2018-2030
6.4.2 Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.4.3 France Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.4.4 U.K. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.4.5 Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.4.6 Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.4.7 Nordic Countries Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.4.8 Benelux Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2018-2030
6.5.2 China Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.5.3 Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.5.4 South Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.5.5 Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.5.6 India Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2018-2030
6.6.2 Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.6.3 Argentina Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2018-2030
6.7.2 Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.7.3 Israel Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.7.4 Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
6.7.5 UAE Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, 2018-2030
7 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies Profiles
7.1 Alchemia Limited
7.1.1 Alchemia Limited Company Summary
7.1.2 Alchemia Limited Business Overview
7.1.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.1.4 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.1.5 Alchemia Limited Key News & Latest Developments
7.2 Alvogen
7.2.1 Alvogen Company Summary
7.2.2 Alvogen Business Overview
7.2.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.2.4 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.2.5 Alvogen Key News & Latest Developments
7.3 Aphios Corporation
7.3.1 Aphios Corporation Company Summary
7.3.2 Aphios Corporation Business Overview
7.3.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.3.4 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.3.5 Aphios Corporation Key News & Latest Developments
7.4 Cellceutix Corporation
7.4.1 Cellceutix Corporation Company Summary
7.4.2 Cellceutix Corporation Business Overview
7.4.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.4.4 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.4.5 Cellceutix Corporation Key News & Latest Developments
7.5 Enanta Pharmaceuticals
7.5.1 Enanta Pharmaceuticals Company Summary
7.5.2 Enanta Pharmaceuticals Business Overview
7.5.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.5.4 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.5.5 Enanta Pharmaceuticals Key News & Latest Developments
7.6 Helix BioMedix
7.6.1 Helix BioMedix Company Summary
7.6.2 Helix BioMedix Business Overview
7.6.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.6.4 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.6.5 Helix BioMedix Key News & Latest Developments
7.7 LegoChem Biosciences
7.7.1 LegoChem Biosciences Company Summary
7.7.2 LegoChem Biosciences Business Overview
7.7.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.7.4 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.7.5 LegoChem Biosciences Key News & Latest Developments
7.8 Lytix Biopharma
7.8.1 Lytix Biopharma Company Summary
7.8.2 Lytix Biopharma Business Overview
7.8.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.8.4 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.8.5 Lytix Biopharma Key News & Latest Developments
7.9 MGB Biopharma Limited
7.9.1 MGB Biopharma Limited Company Summary
7.9.2 MGB Biopharma Limited Business Overview
7.9.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.9.4 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.9.5 MGB Biopharma Limited Key News & Latest Developments
7.10 Microbiotix
7.10.1 Microbiotix Company Summary
7.10.2 Microbiotix Business Overview
7.10.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Major Product Offerings
7.10.4 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global Market (2018-2023)
7.10.5 Microbiotix Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Opportunities & Trends in Global Market
Table 2. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Drivers in Global Market
Table 3. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Restraints in Global Market
Table 4. Key Players of Drugs for Vancomycin-Resistant Enterococcus Faecium in Global Market
Table 5. Top Drugs for Vancomycin-Resistant Enterococcus Faecium Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type
Table 9. List of Global Tier 1 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Vancomycin-Resistant Enterococcus Faecium Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2024-2030
Table 30. Alchemia Limited Company Summary
Table 31. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 32. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 33. Alchemia Limited Key News & Latest Developments
Table 34. Alvogen Company Summary
Table 35. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 36. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 37. Alvogen Key News & Latest Developments
Table 38. Aphios Corporation Company Summary
Table 39. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 40. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 41. Aphios Corporation Key News & Latest Developments
Table 42. Cellceutix Corporation Company Summary
Table 43. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 44. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 45. Cellceutix Corporation Key News & Latest Developments
Table 46. Enanta Pharmaceuticals Company Summary
Table 47. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 48. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 49. Enanta Pharmaceuticals Key News & Latest Developments
Table 50. Helix BioMedix Company Summary
Table 51. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 52. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 53. Helix BioMedix Key News & Latest Developments
Table 54. LegoChem Biosciences Company Summary
Table 55. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 56. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 57. LegoChem Biosciences Key News & Latest Developments
Table 58. Lytix Biopharma Company Summary
Table 59. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 60. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 61. Lytix Biopharma Key News & Latest Developments
Table 62. MGB Biopharma Limited Company Summary
Table 63. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 64. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 65. MGB Biopharma Limited Key News & Latest Developments
Table 66. Microbiotix Company Summary
Table 67. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Offerings
Table 68. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$, Mn) & (2018-2023)
Table 69. Microbiotix Key News & Latest Developments
List of Figures
Figure 1. Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Type in 2022
Figure 2. Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Application in 2022
Figure 3. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in 2022
Figure 8. By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 9. By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 10. By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 12. By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 14. By Region - Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 15. By Country - North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 16. US Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 20. Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 21. France Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 28. China Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 32. India Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 34. Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share, 2018-2030
Figure 37. Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, (US$, Mn), 2018-2030
Figure 41. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
